The FDA and USDA have been conducting a series of half-day meetings around the country to allow public feedback on the challenges veterinarians and producers will face under proposed rules for veterinary oversight of antimicrobial use. This Wednesday, the road show visits Fort Collins, Colorado, a location central to significant beef and dairy production.
The Fort Collins meeting will take place from 8:30 a.m. to 12:30 p.m., at the Natural Resource Research Center, USDA Animal and Plant Health & Inspection Service, Veterinary Services, Centers for Epidemiology & Animal Health, 2150 Centre Ave., Building B, Gray’s Peak Conference Rooms A & B.
The agency’s initiative for judicious use of medically important antimicrobials in medicated feed or drinking water of food-producing animals establishes a framework for phasing out production uses of antimicrobials important in treating humans, and phasing in veterinary oversight of the remaining therapeutic uses of such drugs.
The meetings will focus on challenges, particularly in areas where producers might lack access to adequate veterinary services.
The dates and locations for remaining meetings are:
- May 21, 2013, in Pierre, S.D.
- June 4, 2013, in College Station, Texas
Find details on times and specific locations for each meeting here.
The planned agenda for the meetings is as follows:
- 8:30 to 8:40 a.m. – Welcome/Introduction (FDA)
- 8:40 to 9:25 – Background presentations: Overview of FDA strategy on antimicrobial resistance (FDA), availability of food animal veterinarians in the U.S. (USDA) and veterinarians and antimicrobial use (AVMA).
- 9:25 to 9:35 – Q&A on presentations
- 9:35 to 9:45 – Break
- 9:45 to 11:00 – Open public comment period
- 11:00 to 12:00 -- Focused discussion period, stakeholder input, with focus on current access/use of veterinary services, expected effect of increased veterinary oversight and practical approaches for managing this change.
- 12:00 to 12:30 – Summary of feedback.
You do not need to attend one of the public meetings to provide your comments, and can submit them in either paper or electronic form. Details on FDA’s proposals and directions for submitting comments are available on the Federal Register.